3/24/2026 2:09:36 PM Biotech Review of the Year Issue 13 - out now! By Charlie French Ellen Lambrix Aida Tohala Erik Müürsepp +1 more... Show less We’re pleased to share the 13th edition of our Biotech Review of the Year, bringing together practical legal, regulatory and commercial...
3/24/2026 1:48:17 PM Commercial disputes in the life sciences sector: the complexity of assessing loss By Wes Walker This article is part of our Biotech Review of the Year - Issue 13 publication. Commercial disputes involving life sciences businesses are...
3/24/2026 1:48:15 PM 2026: A year of clarity for the SPC Manufacturing Waiver Regulation? By Luke Norton This article is part of our Biotech Review of the Year - Issue 13 publication. Between 2024 and 2025, there were multiple cases across...
3/24/2026 1:48:12 PM Has biotech litigation entered a new era? By Katie Cambrook Amy Howlett This article is part of our Biotech Review of the Year - Issue 13 publication. 2025 was an important year for biotech patent litigation,...
3/24/2026 1:48:08 PM From factory to bedside: decentralised medicines manufacturing in the UK By Hugo Kent-Egan This article is part of our Biotech Review of the Year - Issue 13 publication. The stated aim of the UK’s regulator for medicines, the...
3/24/2026 1:48:04 PM Trial by name, trial by nature: how lack of data protection harmonisation is hindering European clinical trials By Marc Dautlich Kiran Sidhu This article is part of our Biotech Review of the Year - Issue 13 publication. Europe’s ability to leverage its world-leading academic...
3/24/2026 1:47:26 PM Proposal for a European Biotech Act: will the Commission’s proposal unlock the potential of the health biotech industry in the EU? By Xisca Borrás This article is part of our Biotech Review of the Year - Issue 13 publication. December of 2025 was an exciting month for the life...
3/24/2026 1:47:23 PM Competition authorities in Europe target ‘killer acquisitions’ – what biotech companies need to know By Sophie Lawrance Victoria Yuan This article is part of our Biotech Review of the Year - Issue 13 publication. Competition authorities are increasingly targeting...
3/24/2026 1:47:20 PM Budget 2025: the key tax measures supporting science and innovation By Julia Cockroft Tabitha Reed This article is part of our Biotech Review of the Year - Issue 13 publication. On 26 November 2025, Rachel Reeves delivered her...
3/24/2026 1:47:17 PM Top 10 corporate, tax and employment considerations for early-stage and spin-out biotech companies By Samuel Munday Manon Rattle Tabitha Reed This article is part of our Biotech Review of the Year - Issue 13 publication. Launching and scaling a biotech company offers immense...
3/24/2026 1:47:13 PM Half the population, half the data: addressing the women’s health gap in clinical research By Ellie Handy Laura Harwood Soraya Gajra This article is part of our Biotech Review of the Year - Issue 13 publication. Historically, women have been underrepresented in clinical...
3/24/2026 1:47:10 PM Cell and gene therapy: all aboard the rollercoaster ride... By Claire Smith Adam Coughlin Gabriela Swiderska This article is part of our Biotech Review of the Year - Issue 13 publication. Over the last few years, arguably no other part of the...